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ABSTRACT
Association between Sleep Disturbances and Suicidal Ideation among Opioids
Abusers
By
Aditi Patel

October 27 2017
INTRODUCTION: Several previous studies have documented a relationship between sleep
problems and suicide. However, this association has not been explored specifically among opioid
users. Given that studies have suggested that opioids can interrupt sleep and that opioid users are
more likely to attempt suicide than non-users, it is important to further investigate the association
between sleep disturbance and suicidal ideation, planning, and attempts among opioid abusers.
METHODS: Data from the National Survey on Drug Use and Health 2010-2014 survey were
analyzed to assess whether there was an association between sleep problems and suicidal
ideation, planning and attempts among individuals who report abusing opioid medications.
Prevalence of opioids abusers by demographic characteristics, odds ratios and 95% confidence
intervals unadjusted and adjusted by age, gender & mental health disorders were reported.
RESULTS: Results indicated that opioids abuse was higher in ages 18 to 25 years. Results of
2011 unadjusted and adjusted analyses showed significant associations between sleep
disturbance and suicidal planning. Results of 2012 adjusted analyses showed significant
associations between sleep disturbance and suicidal attempts. Results of 2013 unadjusted and
adjusted analyses showed significant association between sleep disturbance and suicidal ideation
among opioids abusers.
DISCUSSION: This research provided some evidence of an association between sleep
disturbances and suicidal ideations, planning and attempts among opioids abusers using NSDUH
data. This study’s findings can be beneficial for educational and public health prevention
programs to promote a better understanding of sleep disturbance, suicidal ideation, planning, and
attempts among opioid abusers. More research can help to find risk factors and achieve overall
mission of harm reduction among opioids abusers.
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Association between Sleep Disturbances and Suicidal Ideation among Opioids Abusers
Introduction:
The United States (US) opioid epidemic is growing, and it is becoming an important
community health issue in all states (Rudd, Seth, David & Scholl 2015). Drug overdose deaths
increased by three times between 1999 and 2014; among those that occurred during 2014, 60.9%
of these deaths involved opioids (Rudd et al., 2015) and six out of ten overdose deaths involve
opioids as a leading cause of mortality. According to the recent Centers for Disease Control and
Prevention (CDC) report, 91 Americans die every day from opioids overdose (Suicide Overdose,
2016).
According to Substance Abuse and Mental Health Services Administration (SAMHSA),
the number of opioid prescriptions dispensed by US retail pharmacy increased from 76 million in
1999 to 207 million in 2013. The US consumes nearly 100% of worldwide hydrocodone and
consumes 81% of oxycodone. Treatment admissions for opioids abuse other than any other drug
abuse increased from one percent of all admissions in 1997 to five percent in 2007. Prescriptions
for medications such as oxycodone, hydrocodone, and methadone use have increased almost four
times over the last 23 years, and there is a growing concern about opioid misuse in the US
(Rudd, Seth, David & Scholl, 2015). The International Narcotics Control Board Report in 2008
found that the number of hydrocodone prescription dispensed by US pharmacies increased from
25 million to 124 million and for oxycodone increased from 12 million to 53 million between
1999 to 2013.
More than half of fifty states had increased rates of drug overdose deaths from opioids;
decreased rates were attributed to policy changes regarding opioids in some states (Rudd et al.,
2015). According to National Institute on Drug Abuse (NIDA), people who become addicted to
opioids take more and more of the same drug to get higher effects. Opioids abusers can overuse
pain pills using their own prescriptions from doctors or use them for non-medical reasons even
after they do not need pain pills left over from surgery or dental procedures. People with opioids
addiction might steal medicines from loved ones, get them from a friend or buy them from a drug
dealer. Opioids abusers are also more likely to shop around at different pharmacies to fill their
multiple opioids prescriptions. Many risk factors lead people to abuse opioids and use it for nonmedical reasons just like any other types of disease occurring from risk factors. People who have
a history of substance abuse disorders, different types of sleep-disordered breathing, and mental
illness are more likely to abuse opioids than other individuals without these risk factors. Risk
factors also lead people to abuse opioids and use it for non-medical reasons just like any other
types of disease occurring from risk factors. People who have a history of substance abuse
disorders, different types of sleep-disordered breathing, and mental illness disorders are more
likely to abuse opioids than other individuals without these risk factors (Robinson et al., 2017).
The abuse of prescription pain relievers by pregnant women can result in neonatal
abstinence syndrome (NAS), and Anesthesiology report 2014 also showed 14.4 percent of
pregnant women are prescribed an opioid during their pregnancy. Smith and Lipari (2017) found
that an average of 21,000 pregnant women misused opioids in the past month using 2007 to 2012
National Surveys on Drug Use and Health (NSDUH). Although opioid use is lower than nonpregnant women in the same age group, it was still more common among pregnant women who
live below federal poverty line (Smith & Lipari, 2017). Smith & Lipari (2017) also suggest that
prevention and intervention efforts to reduce opioids abuse is necessary among 15-25 years old
8

women group because of that same age group also more likely to abuse opioids than their older
counterparts.
Bohnert et al. (2013) study among addictions treatment patients for opioid use for
reasons related to pain vs. for reasons other than pain relief can provide some insights on the
nonmedical use of opioids among abusers. According to Bohnert et al. (2013) state that people
use opioids for purposes other than pain relief for several reasons such as to receive
pleasure/social enhancement, reduce emotional distress from depressive symptoms, and cope
with negative experiences and emotions by using opioids. Bohnert et al. (2013) also reported the
higher level of non-medical use of opioids for reasons other than pain among people who have
prior drug overdose history, mental disorders, and other substance use history. (2013). Addiction
treatment patients who abuse opioids for reasons other than pain also reported taking higher
doses than people who use opioids for pain relief. There are also higher number points of in
mental health problems disturbances among opioids abusers who use opioids drugs for
nonmedical use for reasons other than pain (Bohnert et al., 2013).
Major concerns are rising related to drug overdose deaths by opioids use (Cheatle, 2011).
For example, previous studies involving opioid users suggest that there may be a relationship
between sleep problems and opioids use (Bernert, 2008). This study is particularly concerning
given that evidence suggests that there is a strong link between sleep disorders and suicide
(Bernert, 2008). There is the possibility of an association between opioids use, sleep disturbance
and suicidal ideation, planning, and attempts. However, this relationship has not been explored
specifically among opioid users. Given that studies have suggested that opioids can interrupt
sleep and that opioid users are more likely to attempt suicide than non-users, it is important to
further investigate the association between sleep problems and suicidal ideation, planning, and
attempts in this population. The purpose of this research is to explore the relationship between
sleep disturbance and suicidal ideation, planning, and attempts among opioid abusers.
Specifically, the following research questions are addressed:
(1) What is the association between sleep disturbance and suicidal ideation, suicide
planning and attempts among opioid abusers reported in the National survey on Drug Use and
Health (NSDUH) dataset from 2010 to 2014?
(2) How do the associations between sleep disturbance and suicidal ideation, planning
and attempts among opioid abusers progressing throughout years 2010 to 2014 NSDUH dataset
change over time?
Understanding the association between sleep disturbance and suicidal ideation may help
doctors and other healthcare professionals who work with people who use opioids to understand
the phenomenon of opioid abusers’ higher risk of sleep disturbance, suicidal ideation, planning
and attempts, and death from opioid overdose.
Quantifying the association using NSDUH data from 2010-2014 will provide significant
opportunity to intervene in the drug overdose epidemic among abusers. In a further literature
review, we will examine opioid addicts’ demographics and characteristics, opioids effects on the
human brain, opioids and sleep disturbance, opioids and suicidal ideation, planning, and
attempts, sleep disturbance and suicidal ideation, planning, and attempts. We will also further
examine the framework of opioids abusers, sleep disturbance, and suicidal ideation, planning,
and attempts in a given national survey on drug use and health data set to point out the findings
in data analysis.
9

Literature Review:
Epidemiology of chronic pain in the US
Opioids are commonly prescribed because they are effective in relieving many types of
pain. Among these many types of pain, the National Institute of Health Statistics survey
indicated that low back pain was the most common (27%), followed by a severe headache or
migraine pain (15%), neck pain (15%) and facial ache or pain (4%). Adults with low back pain
are often in worse physical and mental health than people who do not have low back pain.
According to the same survey which concluded low back pain was the leading cause of pain,
they also reported 100 million Americans are experiencing chronic pain. Freburger et al. also
suggested that lower back pain prevalence increased over the 14 years- interval, from 3.9% in
1992 to 10.2% in 2006. Increases were seen for all adult ages, males, and females and black and
white races. Since 1999, an increasing number of Americans are receiving prescription opioids
for their pain, but they are still reporting the same level of pain as before. According to Barbour
et al., the number of American reported severe joint pain in health survey done by CDC was 10.5
million in 2002, and that same number increased to 14.5 million in 2014 (2016). The Morbidity
and Mortality Weekly Report (MMWR) report on Prevalence of Severe Joint Pain Among
Adults with Doctor-Diagnosed Arthritis between 2002 and 2014 also estimate that the prevalence
of arthritis among US adults is expected to grow 52.5 million in 2010-2012 to 78.4 million by
2040 (Barbour et al., 2016).
According to Robinson et al. (2017) chronic pain affect approximately 100 million
Americans, and sociodemographic, medical history, healthcare access and utilization, selfmanagement barriers, and social support affect how people manage chronic pain. Among chronic
pain population in the USA, middle-aged and older adults make up 80% of prevalence, and they
are more vulnerable than any other group. As earlier stated, factors such as sociodemographic,
medical history, healthcare access and utilization, self-management barriers, and social support
are same factors which more likely to affect minorities and women and also affect chronic pain
effects (Robinson et al., 2017). According to 2009 National Health Interview Survey, women
were twice as likely to experience migraines (severe headaches), or pain in the face or jaw than
men. Johannes et al. (2010) also found some of the subgroups report experiencing pain more
than others in their internet based survey. Ages 55 to 65 years old three times more likely to
experience pain than youngest age group 18-24 years old (Johannes, Le, Zhou, Johnston &
Dworkin, 2010). People with low income, unemployed with disability and females are 20% more
likely to experience chronic pain than any other group (Johannes et al., 2010). There are
approximately 100 million people have chronic pain in America, and the even small number of
those people become addictive to opioids have a serious effect on population health (Volkow,
2014). Opioids also produce a feeling of well-being and pleasure among users, and it directly
affects the rewards part of the brain. Those effects are similar to some illegal drugs such as
heroin. Studies on opioids use support evidence based findings on opioids abuse leading to
heroin epidemic in certain areas of the US (Volkow, 2014).
Definition of opioids
Opioids are a class of medications which are specifically designed to treat pain and can
be highly addictive. Opioids are naturally occurring from the opium poppy plant, semi-synthetic
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ones from natural plants as stating materials and mixing chemical synthetic and synthetic ones
are from total synthetic and petrochemical building blocks (National institute on Drug Abuse
(NIDA), 2017). According to NIDA, the definition of opioid abuse is taking pain prescription
drugs in a dose other than prescribed, using someone else’s prescription and taking them to get
high. Opioids are very effective to treat pain for a short time by taking as prescribed by doctors.
Misused opioids can lead to more dependence and addiction (NIDA, 2017). According to
American Society of Addiction Medicine, addiction is one of the chronic brain reward diseases.
Addiction’s effects such as the inability to abstain, mental impairment, craving, diminished
thinking and dysfunctional emotional response make opioids more harmful and opioids abusers
to more vulnerable to problems such as overdose deaths and injuries.
Epidemiology of opioid use
According to Volkow and McLellan, more than 30% of Americans have some form of
chronic and acute pain, and among old Americans, the prevalence of chronic pain is 40% (2014).
Opioids are more frequently dispensed in US retail pharmacies now than 20 years before.
Volkow and McLellan also found that US retail pharmacies dispensed 85 million prescriptions
for opioids in 1994 compare to recent data about 245 million prescriptions for opioids in 2014.
The study also found that 65% of that prescription was for short-term opioids therapy and 9.6
million to 11.5 million of the adult population are on longer-term opioid therapy (Volkow &
McLellan, 2014).
As a result of the increased use of opioids in the US, there has also been an increase in
the number of deaths related to opioid use/abuse. Thirty-seven percent of the 44,000 drug
overdose deaths were from opioids use compared to 19% of heroin-related deaths in 2013. The
overdose deaths from opioids are due to the current epidemic of opioids abuse. Volkow and
McLellan stated that there were 2.5 million adults were affected by opioids overdose in 2014.
Volkow and McLellan (2016) also stated that heroin is typically cheaper than opioids and it is
easier to obtain in some instances. Opioid users often transition to heroin abuse (Volkow &
McLellan, 2016). There is a relatively small percentage (4%) of addicted persons who transition
to heroin according to Volkow and McLellan (2016) findings; however, that number is growing.
The main source of opioids are prescriptions written by physicians, and some of the physicians
and medical associations also released specific guidelines for prescribing opioids and managing
chronic pain. Opioids misuse often times results from patients seeking prescriptions by “doctorshopping” or going to different pharmacies (Volkow & McLellan, 2016). Many physicians also
admitted that they do not know how to prescribe opioids safely, how to detect abuse or addiction,
and even how to educate their patients about side effects of opioids use (Volkow & McLellan,
2016).
The study by Volkow & McLellan (2016) also found that addicted patients who abstained
from opioids for sometimes, they also have some risk for an opioids overdose. Discontinuation
of opioids reverse the tolerance and physical dependence within days or weeks, but the
underlying effects of addiction stays for years among opioids users (Volkow & McLellan, 2016).
Overdose risk in prisoners after getting out of jail and people who come out of detoxification
program is higher, so early interventions among opioids users are necessary to solve problems
related to opioid abuse (Volkow & McLellan, 2016).
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Demographic Characteristics of Individuals Who Abuse Opioids
According to Zacny et al. (2003), non-medical use of opioids leads to psychological
effects such as impairment or distress, social and interpersonal problems, substance dependence
from addiction effects and suicide attempts. Non-medical use of opioids may lead to different
types of physical and social problems for opioids abusers. According to the CDC opioids drug
overdose report, most of opioids abusers have common characteristics such as obtaining multiple
prescriptions for opioids, taking high doses of opioids, mental or substance abuse disorders and
living in a rural low-income household (2016). The shared characteristics stated above suggest
that suicides can be possible by attempting to get high and leading to deaths from overdose
among same group (Zacny et al., 2003). Most of the times opioids abusers also try to attempt
suicide using drugs in high dose. There is also a similarity between them for higher risk of
overdose and suicide. Often, individuals who abuse opioids also have substance abuse disorders.
The drug overdose report by CDC also suggested that individuals with addiction disorders have a
higher risk of the drug overdose (2016). For this research purpose, it will be important to
examine characteristics of opioids users’ such as gender, mental health, alcohol abuse, other
substance use, sleep problems, and suicidal idealization to get a better understanding of the
association between sleep and suicide among opioids abusers.
According to Tordoff and Ganty, there are three types of major characteristics seen
among opioids abusers (2010). Pseudo-addiction is one the characteristics among opioid users
when their pain is untreated or not treated with the right dose of opioids. Untreated pain and
patient’s fear of recurring pain can lead to illegal drug use and often time these characteristics is
mistaken for addiction among opioid users (Tordoff & Ganty, 2010). The second characteristic is
dependence resulting from the continuous use of opioid prescriptions and resulting tolerance and
withdrawal symptoms from reduced dose. Dependence is to prevent physiological withdrawal,
where addiction is the continued use of the drug, despite its harm. Third type of characteristics is
tolerance among opioids users to either its therapeutic effects or its unwanted side effects.
Tolerance can make opioids users to increase their dose and craving for opioids more. Findings
from Enevoldson suggests that opioid addicts are more likely to experience sleep problems and
suicidal ideation (2004). Nonmedical use of opioids can also lead to panic, depressive, and
psychiatric symptoms. Trémeau et al. (2008) found that opioids use contributes to low serotonin
level in brain, which can contribute to the risk of addiction, sleep disorders and suicide ideation
(2008).
Risk factors for/predictors of opioid abuse
Cochran et al. (2014) examined commercial insurance claims data to differentiate and
elucidate predictors of opioid abuse or dependence diagnoses within two years of filling an
opioid prescription from those who do not receive such a diagnosis within the same time frame.
The researchers found that individuals with interpersonal problems, use of multiple opioids, use
for non-identifiable reasons, and comorbidity with other substance misuses were significant
predictors of opioid abuse and dependence disorders (Cochran et al., 2014). Previous studies
have also suggested that there may be a link between nonmedical use of prescription drugs and
mental health disorders (Cochran et al., 2014). Long term opioids abuse and dependence largely
contributed by non-opioid substance use and mental health disorders (Cochran et al., 2014).
Many mental health diagnoses are one of the major risk factors for opioids misuse, but often
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people hide mental health problems due to stigma in society. Misdiagnosis can lead to opioid use
rather than appropriate psychiatric medication (Cochran et al., 2014). Opioids users were also
more likely to have anxiety, mood, pain, personality disorders, and other kinds of psychotic
disorders; these characteristics may lead them to abuse and become more addicted to opioids.
57.7% of opioid users had another substance use disorder diagnosis compared to 3.4% of
nonusers. Cochran et al., study found 20.7% alcohol dependence, 16.3% other, mixed, or
unspecified drug abuse, 7.1% cocaine dependence among opioids users compared to 0.5%, 0.1%,
and 0.0% among nonusers. These findings are useful to identify opioid abuse characteristics
among people who use opioids for medical purposes (Cochran et al., 2014).
Volkow and McLellan also suggest that one critical issue for treating pain patients is
identifying their risk for abusing pain prescriptions (2016). All prescribers should know risk of
diversion, overdose, and addiction among opioids users. Volkow and McLellan (2016) also
found that not all medical schools have proper curriculum on pain and addiction treatment. Long
term treatment of opioids has questionable benefits and more public health risk. Providers who
have gap in knowledge about opioids long term treatment, their patients are at more risk for
opioids abuse (Volkow & McLellan, 2016). According to Volkow and McLellan, abuse risk is
greatest when the individual has risk factors in all three categories (psychosocial factors, drugrelated factors, and genetic factors) (2016). In the absence of psychosocial and genetic risk
factors, opioids users are less likely to develop the addiction. At the same time, the individual
with a history of substance abuse and psychosocial comorbidity are at increased risk, especially
if treatment with opioids is not monitored by physicians (Volkow & McLellan, 2016).
Consequences of opioid use and abuse
Several research studies suggested sleep disturbance and suicidal ideation as
consequences of opioid use and abuse. According to Cheatle (2011), comorbid depression poses
the greater risk for suicide among people living with pain (2011). It is almost impossible to
determine the number of failed and successful suicides among opioids users because opioids
abuse also leads to overdose. After deaths from overdose, it will be hard to determine if it was
intended or unintended among opioids abusers (Cheatle, 2011). Evidence suggests that there is a
higher risk for suicide among opioids users and support the fact that some overdose deaths from
opioids are intended suicide attempts. The number of opioid-related poisoning increased from
4,000 to 13,800 deaths from 1999 to 2006 and among that 40% of deaths involved opioids use
(Cheatle, 2011). Opioid-related fatal poisonings also support the increased availability of written
prescription of opioids from clinicians. Results from the 2010 SAMHSA also states that
emergency department visits for drug-related suicide attempts increased by 30% and there was a
55% increase in opioid-related attempts between 2005 and 2007. Cheatle (2011) also stated that
committing suicide is a way out for a situation or problem that is causing the extreme problem.
In 2007, 1 in 5 individuals who have been admitted to the ER for suicide-related injury showed
evidence for using prescription opioids (Cheatle, 2011). Risk factors for suicide include the
family history of suicide, history of childhood abuse, previous suicide attempts, history of mental
disorders, history of alcohol and substance abuse, aggressive behaviors, social and work
isolation, fear of seeking help (Cheatle, 2011). Factors such as frequency of suicidal ideation,
poor social support system, being unemployed, being divorced, suffering from chronic illness,
and having psychiatric disorders can also lead to suicide. Chronic illness and pain lead to the
feeling of hopelessness, and resulting frustration, anxiety and loss of control can lead to thinking
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suicide is an easy way out for chronic patients (Cheatle, 2011). According to Franklin (2014),
there has been the major shift in science and policy regarding opioids prescription during the
1980’s to recognize pain as a vital sign, and it is directly or indirectly responsible for increased
prescriptions dispensed by US retail pharmacies and it affected 100,000 deaths from opioids use
to date. The use of prescription opioid medications has increased greatly in the US during the
past two decades; in 2010, there were 16,651 opioid-related deaths. The Drug Abuse Warning
Network also reported 183% increased medical emergencies related to opioids from 2004 to
2011(Dart et al., 2015).
According to Hassett, Aquino and Ilgen (2014), there have been 38000 suicide deaths in
2010 associated with opioids, and for every death, approximately 25 suicide attempts led to
personal injury. In Hassett, Aquino and Ilgen (2014) study, patients experiencing pain expressed
the desire to die to end the pain compared to individuals without pain. Hassett, Aquino, and Ilgen
(2014) report that suicide mortality is associated with greater severity of pain, after controlling
demographic factors, health status, physical functioning, medical comorbidities, sleep duration,
alcohol consumption, body mass index, smoking, and psychological stress factors. Another study
among 260,254 veterans also found 45.27 suicide rate in 100,000 person-years with very mild
pain and a rate of 80.65 suicide rate in 100,000 veterans with very severe pain after controlling
all factors including psychiatric factors (Hassett, Aquino, & Ilgen, 2014). Therefore, evidence
suggests that individuals experiencing pain are more likely to express suicidal ideation compared
to individuals without pain.
Some studies suggested the need of intervention for suicide among opioids users because
evidence suggests they are five times more likely to commit suicide and their risk of suicide is
double that of individuals who are not taking opioids (Hassett, Aquino, and Ilgen, 2014).
Greater pain increases the risk of mortality related to suicide. The presence of Psychiatric
Comorbidity also plays an important role in leading suicide. In the study, 31.0 % of chronic pain
patients with anxiety expressed suicidal ideation compared to 13.0 % of chronic patients without
anxiety (Hassett, Aquino, & Ilgen, 2014). Pain is still the independent factor, but analysis of
other substance use is also necessary to prevent suicide mortality among chronic patients.
According to Hooley, Franklin, and Nock (2014), more than 1 million die by suicide each year
due to some major risk factors responsible for completed suicidal attempts leading to deaths.
Risk factors for include older age, male sex, previous suicide attempts, and the presence of
psychiatric problems. For opioids users, chronic pain is the one of the big factor leading to
suicide because Hooley, Franklin, and Nock (2014) pointed out depression, emotional pain,
desire to escape pain, increased capabilities for suicides, and burdensomeness for belongings
from chronic pain leads to suicide behavior anxiety and hopelessness. According to Cheatle and
Webster, the study among pain treatment for a particular subgroup of patients with non-cancer
pain do experience adverse side effects from opioid therapy (2015). Side effects include
addiction, sleep disorder, cognitive difficulties, sedation and bladder dysfunction. These factors
often lead to the lack of sleep and suicide attempts (Hooley, Franklin, & Nock, 2014).
Literature on association between chronic pain, opioid use and sleep disturbance
According to Finan, Goodin, and Smith, pain greatly influences neurons in the
hypothalamus the part of the brain responsible for behavior by sending a physical and emotional
signal of harm (2013). Sleep is regulated by the same part of the brain which controls pain
signals and behaviors, and sleep also can maintain physiologic systems of the body. Finan, and
14

colleagues suggest that 67-88% of people with chronic pain disorders complained about sleep
and diagnosed insomnia was present among 50% of chronic patients (2013). Chronic pain and
sleep disturbances share some of the common comorbidities such as depression, obesity, and
type 2 diabetes. Development of pain and sleep disturbances indirectly affect each other one way
or another way. Prospective studies have suggested that lack of sleep also increases pain
sensitivity among people and loss of sleep causes nociceptive stimuli (Finan, Goodin, & Smith,
2013).
Angarita, Emadi, Hodges, & Morgan, (2016) also found that dizziness and sleepiness are
common side effects of opioids, and even short-term opioid use leads cognitive effects such as
the ability to make the judgement about the unnecessary use of opioids among chronic pain
patients. Not only initial use, but withdrawal and abstinence from opioids affect sleep same way
by showing effects of increased sleep latency, reduced sleep duration, insomnia, inadequate sleep
quality and quantity and increased drowsiness. Even a single dose of opioids interrupt sleeping
patterns among healthy adults. For example, in one recent study, an electrical scan of the brain
showed the difference between total sleep time, sleep efficiency, sleep latency, total time awake,
and time spent moving among opioid users and nonusers (Angarita et al., 2016). Several
cognitive abnormalities caused by breathing patterns and oxygen intake among people who use
opioids also lead to sleep disturbances. Past research has suggested depressive and anxious
symptoms, nicotine use, pain, and unemployment are major risk factors for poor sleep quality
and opioids users have all of those characteristics most of the time (Angarita et al., 2016). There
is need to identify risk factors associated with individual’s sleep disturbances to avoid side
effects caused by sleep disturbances among opioids users. Better management of sleep
disturbance among opioids users by healthcare providers can stop the harm caused by lack of
sleep.
Several previous studies found that patients with chronic pain can experience sleep
disorder in the long term. There is also a scientific debate about whether opioids have beneficial
or harmful effects on sleep quality and efficiency (Cheatle & Webster 2015). Sleep disordered
breathing is sleep related breathing problems and irregular breathing during sleep. A sleep
disorder can create a headache, irritability and mood swings, and it can sleep disorder can lead to
unintentional opioid overdose attempts among opioids users. According to Cheatle & Webster,
the study among pain treatment for a particular subgroup of patients with non-cancer pain do
experience adverse side effects from opioid therapy (2015). Side effects include addiction, sleep
disorder, cognitive difficulties, sedation and bladder dysfunction. In the non-cancer patient study,
there are greater than 50% of participants reported sleep disorder. Sleep disturbance leads to poor
sleep quality among opioids users, and it can increase their pain intensity (Cheatle & Webster,
2015). Cheatle and Webster also found that there is evidence of sleep disordered breathing from
opioid use and it is one of a risk factor for drug overdose (2015). So far, there are clear paths
leading sleep disturbance to suicide and opioids leading to suicide.
Literature on association between chronic pain, opioid use and suicidality
Suicidal ideation is a continuous process of negative feelings, thoughts and plans.
Prevalence of suicidal ideations, thoughts, and plans are very hard to estimate, but often time
non-fatal suicide attempt finally leads to death by fatal suicide (Arribas-Ibar, Suelves, SnachezNiubo, Domingo-Salvany, & Brugal, 2017). Suicide-related deaths represent 15% of total 15,000
fatal injuries occur daily and among 15-29 years old suicide is the second leading cause of death.
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Mental disorder greatly affects the rate of suicide, but several research studies also suggested that
opioid use may increase the likelihood of fatal and non-fatal suicidal behavior. Drug users more
likely to experience traumatic experiences such as drug-scene crime events, illegal drug market
activities, being in prison and it also contributes to developing ideations about suicide attempts
and planning (Arribas-Ibar et al., 2017). Arribas-Ibar et al.’s study also found 32.7% prevalence
for suicidal ideation among illicit drug users in the treatment facility is much higher than the
general population (2017). Suicide is one of the factors leading to high rate of morbidity and
mortality among drug users. The presence of mental disorders, history of trauma, previous
suicide attempt and stressful events also significantly contribute to suicidal ideation among
opioid users (Arribas-Ibar et al., 2017).
Ilgen, Zivin, Mccammon & Valenstein (2008), also suggested that chronic pain is
associated with depression, anxiety, alcohol and drug abuse or dependence (2008). The
relationship between pain and suicide is also suggested by previous research (Ilgen et al., 2008).
Ilgen et al. also found that 30% of patients seeking treatment for chronic pain reported suicidal
ideation, 37% of patients receiving opioid therapy reported suicidal thoughts, over 20% chronic
patients also disclosed lifetime suicide attempts made by them to their primary providers (2008).
Some the studies also showed evidence of 2-3 times more suicidal ideation among patients with
pain.
Kuramoto et al. suggested that suicidal ideation does not vary between stages level of
nonmedical prescription opioid use such as past two years use or past one-year use, but all levels
of duration of opioid use are responsible for suicidal ideation (2011). Suicidal ideation is also
affected by the withdrawal of opioids use, so continue monitoring for suicide is necessary among
past and present opioids users. In the earlier research, there was a strong link between pain and
suicide, so that also explains the connection between suicide and opioids users by stating most
opioid users have chronic pain. Most of the national data such as NSDUH does not ask the direct
question about pain in the reasons of for opioids use, so the only close causal relationship is
possible between opioids-use and suicide is through statistically and analytically (Kuramoto et
al., 2010). Neurobiological changes caused by opioids may be the mechanism by which opioid
use is associated with suicidal ideation. Mood disorder is common among opioids users, and it is
also one leading risk factor for suicidal planning and attempts (Kuramoto et al., 2010).
Wilson, Compton, Nora, and Volkow suggested that dose, route of administration, coadministration with other drugs, and the conditions text during opioids of use, and expectations
from opioids use are critical to determining major risk factors for addiction and overdose (2006).
Teenagers are at high risk for opioids addiction and its side effects such as sleep disorder and
suicide. A clinical study done by Cheatle found that 32% patients with chronic pain reported
suicide ideation (2011). Clinical interventions suggested that targeting sleep quality and pain
coping techniques can reduce the potential of suicide among opioids users. There are certain
high-risk characteristics such as alcohol dependence, past suicide attempts, suicidal ideation,
poor social support, being unemployed, being divorced, suffering from chronic illness, and
personal belonging loss that may increase the risk for suicide among opioids users (Cheatle,
2011). Risk factors for suicide are very high in opioids populations that it suggests death from
drug overdoses is not to reduce the pain, but some users tried to end their life with high dose
intentionally (Cheatle, 2011). The findings by Cheatle suggest that there is a need for
determining the association between chronic pain and intentional self-harm for clinicians as
guidelines before prescribing pain medicines (2011). Trémeau et al. found those suicide
behaviors among opioid users also affected by the history of aggression and smoking (2008).
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The family history of suicide was also responsible for suicide ideation, attempts, and planning.
The Relationship between Sleep Disturbance and Suicidality
Increasing evidence in research shows sleep disturbance significantly contribute to
suicidal ideation, suicide attempts, and death by suicide (Bernert, Kim, Iwata, & Perlis, 2015).
Depression and mental health disorder are significant implication to determine direct causal
relationship between sleep and suicide. Bernert et al. found that association between suicidal
ideation, behaviors and sleep disturbance exist above and beyond from the depression, but there
are not enough clinical studies about the relationship between sleep and suicide after controlling
depression are available. Insomnia and other sleep disturbance risk factors also offer unique
opportunity to prevent suicide by intervening risk factors (Bernert et al., 2015). Identifying risk
factors for suicide-related to sleep disturbance can strengthen prevention of suicide and research
in coordinated care in the medical world.
Some of the common risk factors for suicide and sleep disturbance include history of
childhood abuse, history of mental disorders, history of alcohol and substance abuse, aggressive
behaviors, social and work isolation, fear of seeking help poor social support system, being
unemployed, being divorced, suffering from chronic illness, and having psychiatric disorders
(Cheatle, 2011). Pigeon, Pinquart, and Conner (2012) suggested that depression did not
moderate the association between insomnia and nightmares and suicidal thoughts and behavior
from their meta-analysis research study. Pigeon, Pinquart, and Conner (2012) study found
smaller association after adjusting for depression, but the result was still significant for sleep and
suicide relationship.
Wong and colleagues also found in their study of adolescence that trouble sleeping is a
strong predictor of subsequent suicide thoughts and self-harm behaviors (2011). Additional
examination of disordered sleep and self-harm by the researchers, which controlled for gender,
parental alcoholism and parental suicidal thoughts, and prior suicidal thoughts or self-harm
behaviors among participants 12–14 years old in statistical modelling, determined that sleep
difficulties/disturbances were predictive of suicidal thoughts and self-harm behaviors at ages 15–
17 (Wong, Brower, & Zucker, 2011). The research team also found that trouble sleeping is easier
to assess in interviews among adolescence in their longitudinal study to determine the
association between trouble sleeping and suicide (2011). The study also suggested future
research for early intervention to reduce sleep problems and consequentially risk of suicide
among adolescence.
In a similar study conducted by McCall (2013), insomnia, hopelessness, and nightmares
were found to be modifiable risk factors for suicide. Hopelessness was identified as the strongest
risk factor for suicide because it was recognized as an independent factor that distinguishes
individuals with depression that have suicide ideation from those without (McCall, 2013).
Serotonin in the brain plays the major role in sleep-related problems, and low level of serotonin
also known as to impair decision-making skills in individuals (McCall, 2013). Poor decision
making choices about life leads to suicidal ideation from that. McCall (2011) findings about
sleep and suicide association are somehow mediated by serotonergic mechanisms. While the
clinical world focuses on controlling infectious disease outbreaks and risk reduction, suicide
continues to rise as a global health threat. Prevention strategies to tackle problems sleep
problems is necessary to stop the threat of suicide from that (McCall, 2011).
Krakow, Ribeiro, Ulibarri, Krakow & Joiner (2011) found suicidal individuals reported
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more sleep disturbances than non-suicidal individuals in their study sample of patients seeking
services at a sleep center. This research has determined that suicidality is positively correlated
with sleep problem severity and chronicity (Krakow et al., 2011). Scientific research is
convincing that sleep disturbances is linked strongly with suicidal ideation-which reveals an
important window of opportunity for investigation when examining patterns of risk specifically
among opioid abusers.
Summary of literature and gaps in literature
According to Bernert and Joiner, suicide kills more Americans than homicides, and
it is the 11th cause of death in the USA (2007). Suicidal behaviors and attempts have the
significant impact on public health and health care cost because more than 400,000 emergency
room visits are the result of suicidal ideations. Identification of risk factors for suicidal behaviors
are necessary for successful prevention efforts to decrease suicidal attempts. Bryan and Rudd
(2012) stated that acute suicidal ideation could resolve within few months, but chronic suicidal
ideation involves greater severity of ideation and attempts. Several studies also already
suggested that acute and chronic suicidal ideation and attempts is associated with social,
psychological, and biological variables (Bryan & Rudd, 2012). In the present research
environment, there is also a need for identifying the link between sleep disturbances and suicidal
ideation. The Substance Abuse and Mental Health Services Administration also listed sleep
disturbance under top 10 warning signs of suicide. This study is necessary to understand
relationships between pain, sleep disturbances, suicide and overdose deaths among opioids users.
Bonar et all study also found the strong link between overdose history and opioids use (2014).
The further analysis from NSDUH can provide the missing link between overdose deaths and
opioids users by suggesting possible mechanisms sleep disturbances and suicidal ideation. The
previous literature review suggested that suicidal ideation is greater among opioids users
compared to non-users and people with withdrawal symptoms also have a greater risk. Increased
rate of overdose deaths and opioids use in the USA also suggest scientific research to stop the
harm among opioids users. Most of the studies found underlying risk factors for opioids users,
but there is not a single study using national data such as NSDUH to explore the association
between sleep disturbance and suicidal ideation among opioids users. Pain is the significant
factor for the lack of sleep, and suicidal ideation and most of the opioids users do suffer from
pain. This research study will help providers to identify high risk for sleep disturbances leading
to suicide and overdose deaths among opioids users. Interventions for risk factors among chronic
pain patients can also help the population health by identifying and intervening possible risk
factors and consequences of opioids use.
Methods
Study Design
The NSDUH study (formerly the National Household Survey on Drug Abuse) was
developed and first implemented in 1971, and is done periodically with the most recent ones in
in 1979, 1982, 1985, 1988, and 1990 through 2014. The Substance Abuse and Mental Health
Services Administration's Center for Behavioral Health Statistics and Quality and Research
Triangle Institute (RTI) International sponsor the NSDUH surveys. RTI International also
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conducts NSDUH surveys each year.
The primary purpose of NSDUH is to measure the prevalence of drug use in the US. The
survey includes several questions on mental health issues, illicit drugs use, alcohol, and tobacco
among members of the US civilian and noninstitutionalized population ages 12 or greater. The
NSDUH consists demographic items and questions about the tobacco, alcohol, marijuana,
inhalants, cocaine, crack, cocaine, heroin, hallucinogens, pain relievers, tranquilizers, stimulants,
and sedatives. Before 1999, the study was conducted using paper-and-pencil interviewing
methods for an interview lasting about an hour.
Prior to 1982, Health Statistics and Quality professionals went to participants’ homes and
administered the surveys (after 1982, RTI nternational was selected to conduct the surveys).
Initial surveys were about 3,000 respondents selected from 50 states in the earlier phase of
NSDUH surveys. Participants completed substance use and other sensitive questions via paper
and pencil, so the interviewer was not aware of answers. Less sensitive questions about
demographics, occupational status, household size, and composition were asked aloud by the
interviewer and recorded in the booklet.
Since 1999, the interview has been conducted using computer-assisted methods. The
survey uses a combination of computer-assisted personal interviewing conducted by an
interviewer and audio computer-assisted self-interviewing by RTI professionals going to selected
participants’ homes. Use of computer assisted methods is designed to provide respondents with a
highly private and confidential means of responses to questions and to increase the level of
honest reporting of illicit drug use and other sensitive behaviors.
Computer assisted methods also created similar state level estimates to paper-pencil methods, but
with a sample size of about 70,000 respondents per year from 50 states for NSDUH surveys each
year.
Since 1999, the survey sample has a 50-state design with an independent, multistage area
probability sample. For 1999 through 2013, the eight states with the largest population were
designated as large sample states with a target sample size of 3,600, while the remaining 42
states and the District of Columbia had target sample of 900. From 2014 through 2017 the
sample design has a more cost-efficient sample allocation to the largest states, while at the same
time maintaining sufficient sample sizes in the smaller states to support small area estimation.
Each NSDUH respondent since 2002 has been given an incentive of $30 in order to facilitate a
larger response rate.
Variables
Opioid Abuse
In order to assess non-medical prescription opioid use in the past year, participants were
asked “How long has it been since you last used any prescription pain reliever that was not
prescribed for you or that you took only for the experience or feeling it caused?” Respondents
were presented with pictures and names of different types of prescription opioids and asked if
they had used them non-medically (SAMHSA, 2014). Respondents were told to exclude over the
counter pain relievers use. If the response indicated nonmedical use during the preceding 12
months, the respondent was classified as a nonmedical prescription opioid user within the past
year. The respondents were also asked the year and age in which they started using prescription
opioids non-medically as well as asked about the time since last use and number of days of use.
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Sleep Disturbance
In order to assess sleep disturbance among abusers for this study, it was necessary to use
two questions related to sleep disturbance. Sleep Disturbance for this study include questions
about whether the respondent reported “having problems sleeping/waking early” and reported
“having sleep problems” to get a better understanding of sleep disturbance among abusers. Two
questions related to sleep disturbances were used in the analysis. There were six possible
responses to two questions used for sleep disturbance in the study. Two different questions
included same responses such as yes, no, don’t know, refused, and legitimate skip for survey
participants. For this study’s main research question, only individuals who answered ‘yes’ were
included in the results.
Suicide Ideation, Planning, and Attempts
In order to assess suicidal ideation, participants were asked about whether, when their
problems are worse, they (1) “think it would be better if they were dead” or (2) “think about
committing suicide”. In order to assess suicidal planning, participants were asked about their
problems are worse, they (1) have “any thoughts or plans of suicide” or (2) “make a suicide
plan.” In order to assess suicidal attempts, participants were asked about whether, when their
problems are worse, they “make a suicide attempt.” Response options for all questions about
suicidal ideation, planning, and attempts include “yes”, “no” or “don’t know”; participants could
also refuse to answer or skip the question. As earlier stated, only individuals who answered ‘yes’
were included to find the association.
Recent Mental Health Disorder
In order to assess the presence of any recent diagnosed mental health disorders mental
health disorders, participants were asked, “Received Any Mental Health Treatment in Past
Year?” Response options included “yes”, “no” or “unknown”. For this question, only
individuals who answered ‘yes’ were included to control mental health disorders for the
relationship between sleep disturbance and suicidal ideation, planning, and attempts.
Data Analysis
To better understand the association between suicidal ideation and sleep disturbance
among opioids abusers, statistical analyses with NSDUH data were conducted using SAS
software. Data analyses were done using single year analysis from 2010 to 2014. There is also
time trend analysis done using all variables from 2010 to 2014 associated with the main question
in this study. The first data analysis was conducted using SAS to assess whether sleep
disturbance was associated with suicidal ideation, planning and attempts among opioid abusers
for 2010- 2014. NSDUH is weighted sample, so comparison between years are not done.
The 3-level model was used with logistic regression analysis. This analysis’ format was similar
to a previous study that used NSDUH, but association among opioids users was done first time.
Odd ratios and 95% confidence intervals were reported to present the result. SAS version 9.4
was used for statistical analyses to find the odds among opioids abusers for sleep disturbance and
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suicidal ideation, planning, and attempts. Due to the complex weighting samples, the SAS
procedures PROC SURVEYFREQ and PROC SURVEYLOGISTIC were used. NOMACR
option was used for each model to estimate results better. The level of significance in this work
was set at α = 0.05.
Results
Table 1 shows the nonmedical prescription opioid use among other drug use, mental
disorders, and demographic characteristics. To be consistent with previous published studies of
NSDUH, some of the common demographic variables are included. There were more female
than male participants that were associated with higher response rate in surveys from 2010 to
2014. Tobacco use and hallucinogens did not have any missing data like other categories of drug
use. Almost all of the demographic variables from 2010 to 2014 had similar number of counts
for responses in a given category. Opioids abuse was higher in ages 18 to 25 years from all years
2010 to 2014. A greater number of opioids abusers also reported tobacco, alcohol, and marijuana
use in all years 2010 to 2014.
Table 1 also includes recoded variables such as Sleep Disturbance, Suicidal Ideation,
Suicidal Planning, and Suicidal attempt by using responses for the questions “when problems
worst have problems sleeping/waking early sleep problems”, “when problems worst think it
would be better if dead”, “when problems worst think about committing suicide”, “when
problems worst make a suicide plan”, “when problems worst make a suicide attempt any
thoughts or plans of suicide”, from NSDUH 2010 - 2014 surveys. Table 1 also provides
frequency and percentage for any mental health treatment received by abusers in the past year.
Table 2 presents results on the association between sleep disturbance and suicidal
ideation among opioids abusers obtained from proc survey logistic method, adjusted by age,
gender, and mental health disorder. The odds ratios across years 2010-2014 ranged from 0.898 to
1.715. In Table 2, OR= 1.715 (CI: 95% 1.132 – 2.600) in 2013 unadjusted and OR= 1.671 (CI:
95% 1.102– 2.533) in adjusted data in same years were significant among opioids abusers, and
suggested higher odds of association between sleep disturbance and suicidal ideation. Some
positive odd ratio given in the table suggested higher odds of association between sleep
disturbance and suicidal ideation among opioids abusers, but they were not significant.
Table 3 presents results on the association between sleep disturbance and suicidal
planning among opioids abusers obtained from proc survey logistic method, adjusted by age,
gender, and mental disorder. The odds ratios across years 2010-2014 ranged from 0.843 to 1.707.
In Table 3, OR= 1.570 (CI: 95% 1.048– 2.352) in 2011 unadjusted and OR= 1.531 (CI: 95%
1.014– 2.313) in adjusted data in same years was significant among opioids abusers, and
suggested higher odds of association between sleep disturbance and suicidal planning. Some
positive odd ratio given in the table suggested higher odds of association between sleep
disturbance and suicidal planning among opioids abusers, but they were not significant enough.
Odd Ratios were negative in year 2010 and 2013 in both unadjusted and adjusted data suggested
negative association between sleep disturbance and suicidal planning among opioids abusers.
Table 4 presents results on the association between sleep disturbance and suicidal
attempts among opioids abusers obtained from proc survey logistic method, adjusted by age,
gender, and mental disorder. The odds ratios across years 2010-2014 ranged from 0.909 to 2.030.
In Table 4, OR= 2.030 (CI: 95% 1.038– 3.968) in 2012 adjusted data was significant among
opioids abusers, and suggested higher odds of association between sleep disturbance and suicidal
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attempts. Some positive odd ratio given in the table suggested higher odds of association
between sleep disturbance and suicidal attempts among opioids abusers, but they were not
significant. Odd Ratios were negative in 2013 both unadjusted and adjusted and in 2014 adjusted
data suggested negative association between sleep disturbance and suicidal attempts among
opioids abusers.
Discussion
Drug overdose by opioids is a major public health concern in recent time. Often time, it is
very hard to determine intentional or unintentional overdose when overdose leads to death. It is
important to understand the association between sleep disturbance and suicidal ideation because
that can provide ways to intervene opioids use and decrease number of overdose deaths among
abusers.
Results from surveys in 2013 indicate sleep disturbance is associated with suicidal
ideation among opioids abusers. Results from surveys in 2011 indicate strong association
between sleep disturbance and suicidal planning among opioids abusers. Results from surveys in
2012 among adjusted data indicate strong association between sleep disturbance and suicidal
attempts among opioids abusers. These results are somewhat aligned with previous research
described in literature review about opioids abusers having sleep problems, suicidal ideation,
planning, and suicidal attempts.
This research makes contributions by giving the understanding of higher odds of
association for sleep disturbances and suicidal ideations, planning and attempts among opioids
abusers using variables and responses given in 2010-2014 NSDUH data. Opioids epidemic is
growing recently, but there are some research gaps for this topic. Knowledge of these research
findings of the association can help early intervention and screening among opioids abusers and
stop overdose deaths.
One of the studies by Webster et al. found that methadone caused more opioid-related
deaths than any other opioids due to physician knowledge gaps, patient nonadherence to other
medicines, medical and mental health comorbidities, other substance use, and payer policies that
mandate methadone as first-line therapy (2011). Opioids related deaths are multifactorial, so
solutions should include all of the factors to decrease harm among people. This research study’s
association results should be taken into consideration for risk evaluation and harm reduction
strategies among opioids abusers.
Another study by Paulozzi and Xi also suggested that opioids use is not the urban
problem anymore, but increased opioids treatment also resulted in more abuse in rural areas in
the USA (2008). This study makes one major contribution by assessing sleep disturbance and
suicidal ideation, planning, and attempts among opioid abusers. The study’s findings of higher
odds of association between sleep disturbance, suicidal ideation, suicidal planning, and attempts
are consistent with previous studies mentioned before about association between sleep problems
and suicide. There is no other study published to show the association between sleep disturbance,
suicidal ideation, suicidal planning and attempts among opioids abusers, so this finding adds
value to public health research. National Survey on Drug Use and Health from 2010 to 2014 did
not show a higher prevalence of nonmedical use of pain relievers, and that could be one of the
limitations for not getting significant results.
In order to assess the sleep disturbance and suicidal ideation, planning, and attempts
among opioid abusers, a longitudinal study needs to be designed to assess the progression of
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sleep disturbance and suicidal ideation, planning, and attempts among opioid abusers over time.
Such a study could identify risk factors associated with sleep and suicide among opioid abusers.
Strategies for preventing progression across sleep disturbance and suicidal ideation, planning,
and attempts among opioid abusers will be invaluable findings. More research can help to find
risk factors and achieve overall mission of harm reduction among opioids abusers.
Strengths and Limitations of studies by NSDUH
NSDUH is the national representative sample of annual estimate about drug use and
mental illness among the noninstitutionalized population in the US. Most of the questions in
NSDUH administered with computer assisted methods, which is designed to provide the private
and confidential mode for respondents. It is also intended to increase the level of honest
reporting of illicit drug use and other sensitive behaviors. Also, the large and dispersed NSDUH
sample enables not only state-level estimates but also estimates for sub-state levels. NSDUH is
useful for many purposes, but it has some limitations. The data are self-reports, and thus the
validity of the data depends on respondents' truthfulness and accurate memory about drug use
and other topics. Some experimental studies suggested the validity of self-reported data and
NSDUH procedures were designed to encourage honesty and recall among participants. Some
underreporting and over reporting is seen in surveys. Underreporting and over reporting were
recoded by RTI international professionals according to answers given by individuals in similar
questions asked during surveys.
Second, the survey is cross-sectional rather than longitudinal. In this survey, individuals
were interviewed only once and were not followed for additional interviews in subsequent years.
Each year's survey provides an overview of drug use prevalence at a particular point in time
rather than how drug use changes over time for the specific group of people. That means we
cannot make casual interpretation between sleep disturbance and suicidal ideation, planning or
attempts among opioids abusers.
Third, because the target population of the survey is defined as the civilian,
noninstitutionalized population of the US, a small proportion of the population is excluded. The
subpopulations excluded are the homeless, members of the active-duty military and individuals
in institutional settings. If excluded populations are opioids abusers with higher odds of
association between sleep disturbance and suicidal ideation, planning or attempts, it is missing
useful data for this study and non-generalizable results.
There was a considerable amount of missing responses for opioid use, suicide and sleep
related questions. Variables were categorized for responses to understand frequency percentage
related to this study. All study variables considered in this analysis were categorical. These
results are displayed in Table 1 for 2010 to 2014. The main reason for not getting any significant
results in years 2010 and 2014 was that those years had slightly low frequency in endorsements
for suicide and sleep related questions included in the SAS analysis. According to Page (2014),
the presence or absence of statistically significant differences has limited value in terms of
accepting or rejecting hypothesis. A non‐significant results for the association between sleep
disturbance and suicidal ideation among opioids abusers during some of the years does not really
imply that the findings is not effective because the presence or absence of statistically significant
is affected by the heterogeneity of samples, small sample sizes and measurement variability and
limitations on hypothesis testing for the research (Page, 2014).
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Conclusion
In summary, this research described the association between sleep disturbances and
suicidal ideation, planning and attempts among opioids abusers. Some significant results from
2011, 2012, and 2013 years indicate a risk for sleep disturbance and suicidal ideation, planning
or attempts among opioids abusers. Not all years’ data unadjusted and adjusted were significant,
so we cannot suggest greater association between sleep and suicide problems among opioid
abusers to be able to generalize. This paper still provides future direction to find the association
using data where the prevalence of opioids uses, sleep problems, and suicidal problems are high.
This study’s findings can also be beneficial for educational and public health prevention
programs to promote a better understanding of sleep disturbance, suicidal ideation, planning, and
attempts among opioid abusers.
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Table 1: Prevalence of opioids abusers by demographic characteristics, NSDUH 2010- 2014
Years
N (%)
Characteristics Category 2010
2011
2012
2013
Reported
Reported
Reported
Reported
opioids Abuse opioids Abuse opioids Abuse opioids Abuse
(N=9120)
(N=9082)
(N=8674)
(N=8094)
Age
12-17
1684
1709
1490
1342
Years Old 18.5%
18.8%
17.2%
16.58%
18-25
4498
4425
4192
3852
Years Old 49.3%
48.7%
48.3%
47.6%
26-34
1277
1259
1315
1234
Years Old 14%
13.9%
15.2%
15.2%
35-49
1250
1162
1177
1162
Years Old 13.7%
12.8%
13.6%
14.4%
50-64
356
463
464
426
Years Old 3.9%
5.1%
5.3%
5.3%
65 or
55
64
66
78
Older
0.6%
0.7%
0.8%
0.9%
Gender
Male
4738
4842
4560
4082
51.9%
53.3%
52.6%
50.4%
Female
4382
4240
4114
4012
48.1%
46.7%
47.4%
49.6%
Tobacco Use
Yes
7570
7461
7035
6521
83%
82.1%
81.1%
80.6%
No
1550
1621
1639
1573
17%
17.8%
18.9%
19.4%
Alcohol
Yes
8516
8460
8049
7506
93.4%
93.1%
92.8%
92.7%
No
603
622
625
588
6.6%
6.8%
7.2%
7.3%
Marijuana
Yes
7197
7165
6840
6354
78.9%
78.9%
78.9%
78.5%
No
1917
1911
1826
1737
21%
21%
21.1%
21.5%
Cocaine
Yes
3478
3444
3296
2925
38.1%
37.9
38%
36.1%
No
5636
5632
5373
5167
61.8%
62%
61.94%
63.8%
Heroin
Yes
597
651
656
655
6.5%
7.2%
7.6%
8.1%
No
8518
8428
8013
7433
93.4%
92.8%
92.4%
91.8%
Hallucinogens Yes
4198
4121
3891
3590
46%
45.4%
44.9%
44.3%
No
4922
4961
4783
4504
53.1%
54.6%
55.1%
55.6%

2014
Reported
opioids Abuse
(N=7966)
1001
12.6%
2621
32.9%
1842
21.3%
1698
8.4%
668
1.7%
136
52.6%
4191
47.4%
3775
81.2%
6466
18.8%
1500
93.1%
7415
6.9%
550
83.3%
6636
20.4%
1628
12.8%
1022
87.1%
6941
12.8%
750
90.5%
7212
45.7%
3637
54.3%
4329
26.6%
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Table 1: Prevalence of opioids abusers by demographic characteristics, NSDUH 2010- 2014
Years
N (%)
Characteristics Category
2010
2011
2012
2013
Reported
Reported
Reported
Reported
opioids
opioids
opioids
opioids
Abuse
Abuse
Abuse
Abuse
(N=9120)
(N=9082)
(N=8674)
(N=8094)
Inhalants
Yes
2710
2474
2340
2087
29.7%
27.2%
26.9%
25.8%
No
6400
6603
6319
5989
70.2%
72.7%
72.8%
74%
Tranquilizers
Yes
365
359
353
3292
4%
3.9%
4.1%
40.7%
NEVER USED
5440
5467
5116
4782
TRANQUILIZERS 59.6%
60.2%
58.9%
59.1%
Stimulants
Yes
2452
2381
2263
2190
26.9%
26.2%
26.1%
27.1%
NEVER USED
6638
6671
6386
5880
STIMULANTS
72.8%
73.4%
73.6%
72.6%
Sedatives
Yes
685
658
610
585
7.5%
7.2%
7.1%
7.2%
NEVER USED
8402
8393
8026
7478
TRANQUILIZERS 92.1%
92.4%
92.5%
92.4%
Mental Health
Yes
1599
1492
1587
1499
Disorder
21.6%
20.3%
22.2%
22.3%
Health
No
5803
5845
5568
5214
78.4%
79.7%
77.8%
77.7%
Sleep
Yes
1528
1548
1567
1515
Disturbance
16.7%
17.0%
18.0%
18.7%
Suicidal
Yes
789
780
837
796
Ideation
8.6%
8.6%
9.6%
9.8%
Suicidal
Planning
Suicidal
Attempt

Yes
Yes

759
2.5%
228
2.4%

800
8.8%
250
2.7%

814
9.4%
288
3.3%

797
9.8%
249
3.0%

2014
Reported
opioids
Abuse
(N=7966)
2117
73.3%
5836
4.3%
342
56.6%
4512
28.5%
2269
71.1
5664
8.5%
676
91.1%
7258
20.1%
1620
23.4%
5306
76.6%
1479
18.6%
759
9.5%
746
9.4%
240
3.0%

31

Table 2: Association between sleep disturbance and suicidal ideation among opioids abusers
2010

2011

2012

2013

2014

Unadjusted
OR (95% CI)

Adjusted*
OR (95%
CI)

Unadjusted
OR (95%
CI)

Adjusted*
OR (95%
CI)

Unadjusted
OR (95%
CI)

Adjusted*
OR (95%
CI)

Unadjusted
OR (95%
CI)

Adjusted*
OR (95%
CI)

Unadjusted
OR (95%
CI)

Adjusted*
OR (95%
CI)

1.309
(0.869,1.974)

1.213
(0.803,
1.833)

1.507
(0.743,
1.504)

1.070
(0.774,
1.480)

1.229
(0.764,
1.975)

1.184
(0.736,
1.904)

1.715***
(1.132,
2.600)

1.671**
(1.102,
2.533)

0.950
(0.688,
1.312)

0.898
(0.640,
1.260)

*Adjusted for age, gender & mental health disorders
** p<0.05
***p<0.01

Table 3: Association between sleep disturbance and suicidal planning among opioids abusers

2010

2011

2012

2013

2014

Unadjusted
OR (95%
CI)

Adjusted*
OR (95%
CI)

Unadjusted
OR (95%
CI)

Adjusted*
OR (95%
CI)

Unadjusted
OR (95%
CI)

Adjusted*
OR (95%
CI)

Unadjusted
OR (95%
CI)

Adjusted*
OR (95%
CI)

Unadjusted
OR (95%
CI)

Adjusted*
OR (95%
CI)

0.974
(0.618,
1.535)

0.943
(0.590,
1.506)

1.570**
(1.048,
2.352)

1.531**
(1.014,
2.313)

1.675
(0.980,
2.865)

1.707
(0.981,
2.969)

0.843
(0.527,
1.349)

0.817
(0.531,
1.257)

1.364
(0.939,
1.980)

1.318
(0.910,
1.908)

*Adjusted for age, gender & mental health disorders
** p<0.05
***p<0.01

Table 4: Association between sleep disturbance and suicidal attempts among opioids abusers
2010
Unadjust
ed
OR
CI
1.119
(0.596,
2.102)

Adjusted*
OR
CI
1.084
(0.559,
2.102)

2011
Unadjuste
d
OR
CI
1.651
(0.907,
3.005)

Adjusted
*
OR
CI
1.555
(0.856,
2.826)

2012
Unadjuste
d
OR
CI
1.924
(0.986,
3.755)

Adjusted*
OR
CI
2.030**
(1.038,
3.968)

2013
Unadjuste
d
OR
CI
0.692
(0.367,
1.305)

Adjusted*
OR
CI
0.683
(0.380,
1.231)

2014
Unadjuste
d
OR
CI
1.034
(0.553,
1.936)

Adjusted*
OR
CI
0.909
(0.490,
1.685)

*Adjusted for age, gender & mental health disorders
** p<0.05
***p<0.01
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